Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Apothecus Pharmaceutical Corp.
WARNING LETTER
•Apothecus Pharmaceutical Corp.•April 30, 2019

Apothecus Pharmaceutical Corp. – FDA Warning Letter, Apr 30, 2019

Record Details

The FDA inspected Apothecus Pharmaceutical Corp. in Hicksville, NY, from April 15-30, 2019, identifying significant CGMP violations for combination products, rendering them adulterated.

Violations include: 1. **Inadequate Investigation of Discrepancies (21 CFR 211.192):** The firm failed to thoroughly investigate out-of-specification (OOS) results and complaints for VCF vaginal contraceptive foam batches #31560 and #31561, including leakage and illegible codes. Despite acknowledging issues, the investigation was not expanded to other batches, and no market action was initiated for the affected batches as stated during the inspection. 2. **Inadequate Quality Control Unit (21 CFR 211.22(a)):** The Quality Unit (QU) lacked sufficient authority and resources, failing to ensure drug quality, including oversight of stability data. 3. **Insufficient Computer System Controls (21 CFR 211.68(b)):** The HPLC data acquisition system lacked controls to prevent data deletion or unauthorized alteration. The laboratory manager had administrative privileges, data was not backed up, and there was no approved procedure for data security or QU review of audit trails.

Required corrective actions include retrospective reviews of OOS results and HPLC data, remediation of OOS investigation and stability programs, comprehensive assessment of the QU's authority and

Company
Apothecus Pharmaceutical Corp.
Inspection date
April 30, 2019
Product type
Drugs
Office
Division of Pharmaceutical Quality Operations I
Person
  • Diana Amador-Toro (District Director)
View Company Profile

ID · f58b01f8-f932-4fcf-9793-d9612d62a769

Violation Codes8
21 U.S.C. 353(g)21 CFR 421 CFR 21021 CFR 211FD&C Act 501(a)(2)(B)21 CFR 211.19221 CFR 211.22(a)21 CFR 211.68(b)

Full citation text and observation details available on the Dashboard.

Other documents for Apothecus Pharmaceutical Corp.
  • 483 - 2024-11-15November 15, 2024
  • 483 - 2023-10-06October 6, 2023
  • 483 - 2021-05-17May 17, 2021
  • 483 - 2019-04-30April 30, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Apothecus Pharmaceutical Corp.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.